Integer signs development and supply agreements with Respicardia

Integer has entered into a new development agreement and a new supply agreement with Respicardia to be the development partner and majority supplier of the rem edē implantable pulse generator and related products for seven years, with the first 5.5 years as exclusive supplier.

“Under the agreements, Integer will be Respicardia’s development partner and majority supplier of the rem edē® implantable pulse generator (IPG) and related products for seven years, the first 5 ½ years as an exclusive supplier.”globenewswire.com

• 1 source
• globenewswire.comInteger Supports Respicardia’s Commercialization in the Central Sleep Apnea Market through Two New AgreementsInteger Holdings CorporationJan 14, 2019

Summarized from public sources; check the original articles before acting on it.